Obesity Clinical Trial
Official title:
A Spinal Cord Injury (SCI) Stakeholder-vetted Education Module to Mitigate Early Cardioendocrine Health Risks Occurring After Spinal Cord Injuries.
The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.
Status | Recruiting |
Enrollment | 250 |
Est. completion date | October 31, 2026 |
Est. primary completion date | October 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. Men and Women with SCI/D aged 18-70 years. 2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below. 3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI. Exclusion Criteria: 1. Pregnancy determined by urine testing in sexually active females. 2. Cognitive impairment that compromises the legitimacy of consent. 3. Grade 3-4 pressure injury at the time of study entry. 4. Prisoners |
Country | Name | City | State |
---|---|---|---|
United States | Baylor Scott & White Institute for Research | Dallas | Texas |
United States | University of Miami - Miami Project to Cure Paralysis | Miami | Florida |
United States | University of Minnesota Rehabilitation | Minneapolis | Minnesota |
United States | McGuire Research Institute Richmond VA Medical Center | Richmond | Virginia |
United States | MedStar National Rehabilitation Network | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
University of Miami | National Institute on Disability, Independent Living, and Rehabilitation Research |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Effectiveness of education modules as determined in the Knowledge Test | Effectiveness as determined by the number of correct answers on the Knowledge Test where the higher number of correct answers indicates increased knowledge of the information provided. | baseline, up to 6 months | |
Secondary | Change in Body Weight as determined by kilograms (kg) | Body weight will be measured in kilograms | baseline, up to 6 months | |
Secondary | Change in Body composition as determined by Dual X-ray Absorptiometry (DXA) | Body composition will be measured in grams using DXA | baseline, up to 6 months | |
Secondary | Change in Body composition as determined by Dual X-ray Absorptiometry (DXA) in Percentage | Body composition will be expressed as a percentage of body fat (BF) using DXA | baseline, up to 6 months | |
Secondary | Change in sugar metabolism as determined by Insulin resistance (IR) | Sugar metabolism will be determined as IR calculated using the formula (fasting serum glucose*fasting serum insulin/22.5). Lower values indicate a higher degree of insulin sensitivity. Fasting values are obtained from blood samples | baseline, up to 6 months | |
Secondary | Change in Quality of Life (QoL) as measured by Quality Index Spinal Cord Injury Version III | A composite score will be obtained to assess change in QoL using a six-point Likert scale. Scores for satisfaction section range from "1- very satisfied" to "6-very dissatisfied". On the important section scoring ranges from "1-very important" to "6- very unimportant" | baseline, up to 6 months | |
Secondary | Change in Quality of Life (QoL) Using the International Spinal Cord Injury Basic Data Set | QoL values will be determined using a scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied). | baseline, up to 6 months | |
Secondary | Change in heart disease risk as determined by cholesterol | Risk of heart disease will be measured from a blood sample in mg/dL | baseline, up to 6 months. | |
Secondary | Change in heart disease risk as determined by blood pressure (BP) | BP will be measured in mmHg using an arm cuff | baseline, up to 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |